84 related articles for article (PubMed ID: 16584526)
1. Subclinical hypothyroidism and mortality in women with type 2 diabetes.
Chubb SA; Davis WA; Davis TM
Clin Endocrinol (Oxf); 2006 Apr; 64(4):476-7. PubMed ID: 16584526
[No Abstract] [Full Text] [Related]
2. Subclinical hypothyroidism is associated with reduced all-cause mortality in patients with type 2 diabetes.
Sathyapalan T; Manuchehri AM; Rigby AS; Atkin SL
Diabetes Care; 2010 Mar; 33(3):e37. PubMed ID: 20190285
[No Abstract] [Full Text] [Related]
3. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
[TBL] [Abstract][Full Text] [Related]
4. Re: Subclinical thyroid dysfunction and mortality in type 2 diabetes.
Badshah I; Chubb SAP; Davis WA; Davis TME
J Diabetes Complications; 2017 Sep; 31(9):1474. PubMed ID: 28645682
[No Abstract] [Full Text] [Related]
5. Serum phosphorus and cardiovascular mortality in type 2 diabetes.
Chonchol M; Dale R; Schrier RW; Estacio R
Am J Med; 2009 Apr; 122(4):380-6. PubMed ID: 19332233
[TBL] [Abstract][Full Text] [Related]
6. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis.
Singh S; Duggal J; Molnar J; Maldonado F; Barsano CP; Arora R
Int J Cardiol; 2008 Mar; 125(1):41-8. PubMed ID: 17434631
[TBL] [Abstract][Full Text] [Related]
7. Subclinical hypothyroidism in women with type 2 diabetes.
Díez JJ; Iglesias P
Clin Endocrinol (Oxf); 2005 Oct; 63(4):479-80. PubMed ID: 16181245
[No Abstract] [Full Text] [Related]
8. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women.
Juutilainen A; Lehto S; Rönnemaa T; Pyörälä K; Laakso M
Diabetes Care; 2007 Feb; 30(2):292-9. PubMed ID: 17259497
[TBL] [Abstract][Full Text] [Related]
9. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
10. Subclinical hypothyroidism and cardiovascular disease.
Crapo LM
Arch Intern Med; 2005 Nov; 165(21):2451-2. PubMed ID: 16314538
[No Abstract] [Full Text] [Related]
11. [Management of diabetes in cardiac diseases].
Işik S; Delibaşi T; Berker D; Aydin Y; Güler S
Anadolu Kardiyol Derg; 2009 Jun; 9(3):238-47. PubMed ID: 19520659
[TBL] [Abstract][Full Text] [Related]
12. Body mass index and the risk of total and cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Heart; 2009 Mar; 95(6):454-60. PubMed ID: 18697804
[TBL] [Abstract][Full Text] [Related]
13. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes.
Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G
Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252
[TBL] [Abstract][Full Text] [Related]
14. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
[TBL] [Abstract][Full Text] [Related]
15. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects.
Anand DV; Lahiri A; Lim E; Hopkins D; Corder R
J Am Coll Cardiol; 2006 May; 47(9):1850-7. PubMed ID: 16682312
[TBL] [Abstract][Full Text] [Related]
16. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
Targher G; Bertolini L; Zoppini G; Lippi G; Zenari L
Diabetes Care; 2007 Jun; 30(6):e51; author reply e52. PubMed ID: 17526813
[No Abstract] [Full Text] [Related]
17. Evaluating cardiovascular mortality in type 2 diabetes patients: an analysis based on competing risks Markov chains and additive regression models.
Rosato R; Ciccone G; Bo S; Pagano GF; Merletti F; Gregori D
J Eval Clin Pract; 2007 Jun; 13(3):422-8. PubMed ID: 17518809
[TBL] [Abstract][Full Text] [Related]
18. Does lowering of blood glucose improve cardiovascular morbidity and mortality?
Iqbal N; Rubenstein AH
Clin J Am Soc Nephrol; 2008 Jan; 3(1):163-7. PubMed ID: 18178783
[No Abstract] [Full Text] [Related]
19. High-normal blood pressure and future risks a new concern for clinicians?
Nilsson PM
Eur Heart J; 2007 Dec; 28(23):2832-3. PubMed ID: 17986467
[No Abstract] [Full Text] [Related]
20. Prediction of mortality in type 2 diabetes from health-related quality of life (ZODIAC-4).
Kleefstra N; Landman GW; Houweling ST; Ubink-Veltmaat LJ; Logtenberg SJ; Meyboom-de Jong B; Coyne JC; Groenier KH; Bilo HJ
Diabetes Care; 2008 May; 31(5):932-3. PubMed ID: 18319325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
